The pathophysiology of T2DM involves reduced insulin secretion, exalted production of glucagon, increased gluconeogenesis, neurotransmitter dysfunction and insulin resistance, lipolysis, renal glucose reabsorption, diminished incretin effect, and defective absorption of glucose in muscle, liver-fat signaling axis. The gene discussed is GCG; the disease is type 2 diabetes mellitus.